CytomX Therapeutics, Inc. (CTMX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -25.55M | -23.24M | -15.55M | -15.75M | -21.04M | -19.91M | -20.73M | -19.55M | -26.05M | -21.96M | -18.24M | -25.18M | 9.35M | -1.39M | -33.84M | -34.24M | -41.31M | -31.19M | -29.7M | -28.2M |
| Operating CF Margin % | -249.06% | -3505.73% | -260.74% | -84.43% | -41.33% | -52.26% | -62% | -77.84% | -62.81% | -82.55% | -69.14% | -101.84% | 39.78% | -6.93% | -303.62% | -266.37% | -457% | -158.12% | -168.87% | -173.13% |
| Operating CF Growth % | -21.41% | -16.75% | 24.99% | 19.42% | 19.21% | 9.36% | -13.63% | 22.36% | -378.59% | -1475.54% | 46.1% | 26.46% | 122.63% | 95.53% | -13.95% | -21.41% | -37.99% | -78.99% | -20.35% | -129.04% |
| Net Income | -18.25M | -26.51M | -14.23M | -154K | 23.52M | 18.88M | 5.74M | -6.53M | 13.79M | 837K | 2.99M | -1.09M | -3.31M | -8.78M | -23.3M | -24.18M | -31.98M | -26.23M | -22.58M | -19.24M |
| Depreciation & Amortization | 37K | 510K | 134K | 347K | 385K | 413K | 429K | 459K | 467K | 486K | 1.43M | 1.53M | 595K | 1.49M | 623K | 1.45M | 602K | 1.48M | 1.47M | 1.45M |
| Stock-Based Compensation | 4.71M | 1.48M | 1.5M | 1.43M | 2.01M | 1.88M | 2M | 1.88M | 1.91M | 2.55M | 0 | 0 | 2.41M | 0 | 2.69M | 0 | 3.37M | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 620K | 844K | -3.58M | 711K | 627K | 376K | -188K | -429K | -880K | -1.26M | -707K | 646K | -634K | -16.36M | 848K | 4.47M | 809K | -28.73M | 3.17M | 3.56M |
| Working Capital Changes | -12.66M | 434K | 622K | -18.09M | -47.59M | -41.46M | -28.7M | -14.93M | -41.33M | -24.58M | -21.95M | -26.27M | 10.29M | 22.25M | -14.71M | -15.98M | -14.11M | 22.29M | -11.76M | -13.97M |
| Change in Receivables | 1.37M | -384K | 240K | 87K | 1.15M | 249K | -577K | 10.4M | -9.74M | -1.01M | -516K | -813K | 34.9M | -34.21M | -696K | -58K | -232K | 97K | 44K | -175K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 67K | 655K | 0 | -49K | -804K | -261K | 811K | -1.43M | 581K | -328K | 676K | -1.16M | -618K | -2.37M | 3.29M | 216K | -1.06M | 1.22M | -185K | -881K |
| Cash from Investing | -192.78M | -14.42M | 439K | -76.36M | 30.6M | 15.13M | 18.17M | 21.51M | 44.88M | 12.87M | -42.94M | 26.04M | -146.64M | 99.82M | -410K | -412K | -736K | -245K | 9.73M | -46.01M |
| Capital Expenditures | 0 | -201K | 127K | -27K | -119K | -80K | -19K | -96K | -115K | -266K | -9K | -517K | -48K | -182K | -410K | -412K | -736K | -245K | -268K | -114K |
| CapEx % of Revenue | - | 30.32% | 2.13% | 0.14% | 0.23% | 0.21% | 0.06% | 0.38% | 0.28% | 1% | 0.03% | 2.09% | 0.2% | 0.9% | 3.68% | 3.21% | 8.14% | 1.24% | 1.52% | 0.7% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 312K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 234.49M | 16.64M | 253K | 93.55M | 0 | 2.25M | 0 | 5.1M | 174K | 244K | 29.67M | 317K | 0 | 190K | 0 | 451K | 7K | 683K | 104K | 691K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 234.49M | 16.64M | 0 | 93.55M | 0 | 2.07M | 0 | 5.1M | 174K | 0 | 29.67M | 317K | 0 | 190K | 0 | 451K | 0 | 683K | 104K | 108.3M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 253K | 0 | 0 | 183K | 0 | 0 | 0 | 244K | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 0 | 0 | -107.6M |
| Net Change in Cash | 16.16M | -21.02M | -14.86M | 1.44M | 9.55M | -2.52M | -2.56M | 7.06M | 19.01M | -8.85M | -31.51M | 1.18M | -137.29M | 98.61M | -34.25M | -34.2M | -42.04M | -30.75M | -19.86M | -73.52M |
| Free Cash Flow | -25.55M | -23.44M | -15.42M | -15.78M | -21.16M | -19.99M | -20.75M | -19.64M | -26.16M | -22.23M | -18.25M | -25.7M | 9.3M | -1.58M | -34.25M | -34.65M | -42.05M | -31.44M | -29.97M | -28.31M |
| FCF Margin % | -249.06% | -3536.05% | -258.61% | -84.58% | -41.56% | -52.47% | -62.06% | -78.22% | -63.09% | -83.55% | -69.18% | -103.93% | 39.58% | -7.83% | -307.29% | -269.58% | -465.14% | -159.36% | -170.4% | -173.83% |
| FCF Growth % | -20.73% | -17.29% | 25.67% | 19.67% | 19.11% | 10.08% | -13.68% | 23.55% | -381.26% | -1310.47% | 46.72% | 25.84% | 122.12% | 94.99% | -14.3% | -22.38% | -35.98% | -75.9% | -17.72% | -129.17% |
| FCF per Share | -0.14 | -0.14 | -0.09 | -0.12 | -0.24 | -0.25 | -0.24 | -0.23 | -0.32 | -0.33 | -0.23 | -0.39 | 0.14 | -0.02 | -0.52 | -0.53 | -0.64 | -0.48 | -0.46 | -0.44 |
| FCF Conversion (FCF/Net Income) | 1.40x | 0.88x | 1.09x | 102.29x | -0.89x | -1.05x | -3.61x | 2.99x | -1.89x | -26.24x | -6.10x | 23.16x | -2.82x | 0.16x | 1.16x | 1.16x | 1.29x | 1.19x | 1.32x | 1.47x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |